ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 4.500
+0.200 (4.65%)
May 26, 2026, 4:35 PM GMT
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 28.08 million as of May 26, 2026. Its market cap has increased by 66.72% in one year.
Market Cap
28.08M
Enterprise Value
27.68M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.50
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 28.08M, a decrease of -22.26%. That is a compound annual growth rate of -1.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 28.08M | -9.92% |
| Dec 31, 2025 | 31.17M | 521.13% |
| Dec 31, 2024 | 5.02M | -27.71% |
| Dec 29, 2023 | 6.94M | 13.16% |
| Dec 30, 2022 | 6.13M | -62.85% |
| Dec 31, 2021 | 16.51M | -50.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| hVIVO | 55.65M |
| Hemogenyx Pharmaceuticals | 46.92M |
| Poolbeg Pharma | 35.54M |
| Sareum Holdings | 28.41M |
| SkinBioTherapeutics | 25.14M |
| Arecor Therapeutics | 24.92M |
| Aptamer Group | 19.87M |
| Palatin Technologies | 19.12M |